Skip to main content
. 2018 Mar 26;58(6):814–822. doi: 10.1002/jcph.1077

Figure 2.

Figure 2

Cumulative mean urinary excretion (Ae) of SBECD in subjects with varying degrees of renal function after IV dosing of 2400 mg SBECD from either 300 mg IV delafloxacin (A) or IV placebo (B). IV indicates intravenous; SBECD, sulfobutylether‐β‐cyclodextrin.